RUNX3 is frequently down-regulated in gastric, breast, colorectal, renal, and hepatocellular cancers through point mutations, promoter hypermethylation, and cytoplasmic translocation [50,51]. The gene discussed is RUNX3; the disease is hepatocellular carcinoma.